7320
L.F. Yeh et al. / Tetrahedron 68 (2012) 7317e7321
4.2.3. Ethyl 2-(5-(3-bromophenyl)-2,4-bis(hydroxymethyl)cyclopent-
3.60 (d, J¼4.1 Hz, 1H), 3.09 (d, J¼15.8 Hz, 1H), 2.86e2.80 (m, 2H),
2.43e2.35 (m, 2H), 1.17 (t, J¼7.2 Hz, 3H) ppm; 13C NMR (125 MHz,
1-en-1-yl)acetate (3c). Purification: EA/hexane¼3:1 (Rf¼0.33) to
give 3c as a colorless oil. ½a D20
ꢂ
þ80.4 (c¼1.3, CH2Cl2); IR (CH2Cl2):
n
CDCl3):
d
¼172.4, 158.4, 140.4, 135.6, 133.8, 128.9, 114.1, 66.4, 61.2,
3307, 2920, 2847, 1643, 1470, 1261, 1065 cmꢁ1; 1H NMR (500 MHz,
59.4, 57.9, 55.3, 48.5, 36.8, 32.6, 14.0 ppm; HRMS (ESI) m/z calcd for
C18H24O5 (MþþNa) 343.1516, found 343.1521. The enantiomeric
excess (95% ee) was determined by HPLC with AD-H column (i-
CDCl3)
d
¼7.34 (d, J¼8.2 Hz, 1H), 7.28 (s, 1H), 7.16 (dd, J¼7.8 and
7.8 Hz, 1H), 7.07 (d, J¼7.7 Hz, 1H), 4.24 (dd, J¼19.7 and 13.0 Hz, 2H),
4.07e3.96 (m, 2H), 3.67e3.65 (m, 3H), 3.10 (d, J¼15.7 Hz, 1H),
2.86e2.79 (m, 2H), 2.44e2.34 (m, 2H), 1.17 (t, J¼7.2 Hz, 3H) ppm;
PrOH/hexanes: 5/95; flow rate: 1.0 mL/min;
(major)¼60.99 min; tR (minor)¼82.05 min.
l
¼220 nm); tR
13C NMR (125 MHz, CDCl3):
d
¼172.0,146.2, 141.6,132.3, 130.9, 130.2,
For recovery acetate (1f): spectroscopic data are in agreement
with racemic substrate 1f. Yield: 46% (15 mg). The enantiomeric
excess (76% ee) was determined by HPLC with AD-H column (i-
129.8, 126.7, 122.8, 65.9, 61.2, 59.3, 58.2, 48.4, 36.7, 32.6, 14.0 ppm;
HRMS (ESI) m/z calcd for C17H21BrO4 (MþþNa) 391.0518, found
391.0521. The enantiomeric excess (95% ee) was determined by
HPLC with AD-H column (i-PrOH/hexanes: 5/95; flow rate: 1.0 mL/
PrOH/hexanes: 10/90; flow rate: 1.0 mL/min;
(major)¼12.43 min; tR (minor)¼10.82 min.
l¼254 nm); tR
min;
l
¼220 nm); tR (major)¼42.98 min; tR (minor)¼47.78 min.
For recovery acetate (1c): spectroscopic data are in agreement
with racemic substrate 1c. Yield: 46% (17 mg). The enantiomeric
excess (85% ee) was determined by HPLC with OD-H column (i-
4.2.7. Ethyl 2-(2,4-bis(hydroxymethyl)-5-(3-methoxyphenyl)cyclo-
pent-1-en-1-yl)acetate (3g). Purification: EA/hexane¼3:1 (Rf¼0.32)
to give 3g as a colorless oil. ½a D21
ꢂ
þ90.2 (c¼0.3, CH2Cl2); IR (CH2Cl2):
n
PrOH/hexanes: 5/95; flow rate: 0.5 mL/min;
(major)¼23.75 min; tR (minor)¼27.89 min.
l¼220 nm); tR
3380, 2920, 2847,1725,1601,1584,1552,1487,1261,1181,1034 cmꢁ1
;
1H NMR (500 MHz, CDCl3)
d
¼7.21 (dd, J¼7.9 Hz, 1H), 6.76e6.73 (m,
2H), 6.68 (s,1H), 4.23 (s, 2H), 4.05e3.96 (m, 2H), 3.79 (s, 3H), 3.68 (d,
J¼5.7 Hz, 2H), 3.62 (s,1H), 3.09 (d, J¼15.6 Hz,1H), 2.89e2.80 (m, 2H),
2.43e2.39 (m, 2H), 1.16 (t, J¼7.2 Hz, 3H) ppm; 13C NMR (125 MHz,
4.2.4. Ethyl 2-(5-(4-chlorophenyl)-2,4-bis(hydroxymethyl)cyclopent-
1-en-1-yl)acetate (3d). Purification: EA/hexane¼3:1 (Rf¼0.35) to
3d give as a colorless oil. ½a D25
ꢂ
þ96.4 (c¼0.5, CH2Cl2); IR (CH2Cl2):
n
CDCl3):
d¼172.3, 159.9, 145.3, 141.0, 133.1, 129.6, 120.4, 113.7, 111.8,
3432, 2955, 2920, 2852, 1710, 1649, 1555, 1490, 1365, 1255, 1193,
66.4, 61.1, 59.4, 58.7, 55.2, 48.5, 36.9, 32.6,14.0 ppm; HRMS (ESI) m/z
calcd for C18H24O5 (MþþNa) 343.1529, found 343.1521. The enan-
tiomeric excess (91% ee) was determined by HPLC with AD-H col-
1088, 1028 cmꢁ1
;
1H NMR (500 MHz, CDCl3)
d¼7.26 (d, J¼8.3 Hz,
2H), 7.08 (d, J¼8.4 Hz, 2H), 4.24 (s, 2H), 4.05e3.94 (m, 2H),
3.67e3.66 (m, 3H), 3.08 (d, J¼15.6 Hz, 1H), 2.86e2.79 (m, 2H),
2.42e2.33 (m, 2H), 1.16 (t, J¼7.2 Hz, 3H) ppm; 13C NMR (125 MHz,
umn (i-PrOH/hexanes: 5/95; flow rate: 1.0 mL/min;
(major)¼66.82 min; tR (minor)¼76.62 min.
l
¼220 nm); tR
CDCl3):
d
¼172.0, 142.2, 141.3, 132.7, 132.4, 129.3, 128.8, 66.1, 61.2,
For recovery acetate (1g): spectroscopic data are in agreement
with racemic substrate 1g. Yield: 31% (10 mg). The enantiomeric
excess (88% ee) was determined by HPLC with AD-H column (i-
59.4, 58.0, 48.6, 36.8, 32.6, 14.0 ppm; HRMS (ESI) m/z calcd for
C17H21ClO4 (MþþNa) 347.1030, found 347.1026. The enantiomeric
excess (91% ee) was determined by HPLC with IA column (i-PrOH/
PrOH/hexanes: 5/95; flow rate: 0.3 mL/min;
(major)¼43.26 min; tR (minor)¼39.36 min.
l¼254 nm); tR
hexanes: 5/95; flow rate: 1.0 mL/min;
35.08 min; tR (minor)¼41.41 min.
l
¼220 nm); tR (major)¼
For recovery acetate (1d): spectroscopic data are in agreement
with racemic substrate 1d. Yield: 37% (12 mg). The enantiomeric
excess (85% ee) was determined by HPLC with OD-H column (i-
4.2.8. Ethyl 2-(2,4-bis(hydroxymethyl)-5-(p-tolyl)cyclopent-1-en-1-
yl)acetate (3h). Purification: EA/hexane¼3:1 (Rf¼0.41) to give 3h
as a colorless oil. ½a D24
ꢂ
þ81.5 (c¼0.5, CH2Cl2); IR (CH2Cl2):
n
3210,
PrOH/hexanes: 10/90; flow rate: 1.0 mL/min;
(major)¼6.76 min; tR (minor)¼7.62 min.
l¼254 nm); tR
2920, 2852, 1731, 1552, 1510, 1258, 1178, 1025 cmꢁ1 1H NMR
;
(500 MHz, CDCl3)
d
¼7.10 (d, J¼8.0 Hz, 2H), 7.02 (d, J¼8.0 Hz, 2H),
4.26e4.20 (m, 2H), 4.05e3.94 (m, 2H), 3.67 (d, J¼5.8 Hz, 2H), 3.61
(d, J¼4.2 Hz, 1H), 3.10 (d, J¼15.6 Hz, 1H), 2.86e2.80 (m, 2H),
2.41e2.35 (m, 2H), 2.32 (s, 3H), 1.15 (t, J¼7.2 Hz, 3H) ppm; 13C NMR
4.2.5. Ethyl 2-(5-(3-chlorophenyl)-2,4-bis(hydroxymethyl)cyclopent-
1-en-1-yl)acetate (3e). Purification: EA/hexane¼3:1 (Rf¼0.35) to
give 3e as a colorless oil. ½a D21
ꢂ
þ82.7 (c¼0.5, CH2Cl2); IR (CH2Cl2):
n
(125 MHz, CDCl3):
d
¼172.6, 140.8, 140.7, 136.4, 133.7, 129.6, 128.0,
3460, 2920, 2858, 1640, 1473, 1365, 1076, 1023 cmꢁ1
;
1H NMR
66.6, 61.4, 59.6, 58.4, 48.7, 37.0, 32.8, 21.2, 14.1 ppm; HRMS (ESI) m/z
calcd for C18H24O4 (MþþNa) 327.1570, found 327.1572. The enan-
tiomeric excess (94% ee) was determined by HPLC with AD-H col-
(500 MHz, CDCl3)
d
¼7.24e7.18 (m, 2H), 7.12 (s,1H), 7.03 (d, J¼7.2 Hz,
1H), 4.27e4.22 (m, 2H), 4.07e3.96 (m, 2H), 3.68e3.66 (m, 3H), 3.10
(d, J¼15.7 Hz, 1H), 2.87e2.80 (m, 2H), 2.42e2.35 (m, 2H), 1.17 (t,
umn (i-PrOH/hexanes: 10/90; flow rate: 1.0 mL/min;
(major)¼13.77 min; tR (minor)¼17.71 min.
l
¼220 nm); tR
J¼7.2 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3):
¼172.0, 145.9,
d
141.5, 134.5, 132.4, 129.9, 128.0, 126.9, 126.2, 66.1, 61.2, 59.4, 58.3,
48.5, 36.7, 32.7, 14.0 ppm; HRMS (ESI) m/z calculated for C17H21ClO4
(MþþNa) 347.1024, found 347.1026. The enantiomeric excess (94%
ee) was determined by HPLC with AD-H column (i-PrOH/hexanes:
For recovery acetate (1h): spectroscopic data are in agreement
with racemic substrate 1h. Yield: 45% (14 mg). The enantiomeric
excess (79% ee) was determined by HPLC with AD-H column (i-
PrOH/hexanes: 5/95; flow rate: 0.5 mL/min;
(major)¼21.46 min; tR (minor)¼18.44 min.
l¼254 nm); tR
5/95; flow rate: 0.5 mL/min;
(minor)¼92.78 min.
l
¼220 nm); tR (major)¼81.56 min; tR
For recovery acetate (1e): spectroscopic data are in agreement
with racemic substrate 1e. Yield: 46% (15 mg). The enantiomeric
excess (81% ee) was determined by HPLC with AD-H column (i-
4.2.9. Ethyl 2-(2,4-bis(hydroxymethyl)-5-(naphthalen-2-yl)cyclopent-
1-en-1-yl)acetate (3i). Purification: EA/hexanes¼3:1 (Rf¼0.38) to
give as a colorless oil. ½a D25
ꢂ
þ98.6 (c¼0.6, CH2Cl2); IR (CH2Cl2):
n
PrOH/hexanes: 5/95; flow rate: 0.5 mL/min;
(major)¼23.82 min; tR (minor)¼18.85 min.
l¼254 nm); tR
3205, 2920, 2847, 1728, 1711, 1598, 1550, 1368, 1176, 1025 cmꢁ1; 1H
NMR (500 MHz, CDCl3)
d
¼7.81e7.75 (m, 3H), 7.59 (s, 1H), 7.48e7.42
(m, 2H), 7.27 (dd, J¼6.8 and 1.6 Hz, 1H), 4.28 (s, 2H), 3.99e3.84 (m,
3H), 3.73 (d, J¼6.0 Hz, 2H), 3.11 (d, J¼15.6 Hz, 1H), 2.92e2.87 (m,
2H), 2.53e2.44 (m, 2H), 1.02 (t, J¼7.2 Hz, 3H) ppm; 13C NMR
4.2.6. Ethyl 2-(2,4-bis(hydroxymethyl)-5-(4-methoxyphenyl)cyclo-
pent-1-en-1-yl)acetate (3f). Purification: EA/hexane¼3:1 (Rf¼0.32)
to give 3f as a colorless oil. ½a D24
ꢂ
þ62.4 (c¼0.7, CH2Cl2); IR (CH2Cl2):
n
(125 MHz, CDCl3):
d
¼172.2, 141.1, 141.0, 133.5, 133.1, 132.5, 128.5,
3210, 2915, 2847, 1728, 1552, 1510, 1246, 1176, 1028 cmꢁ1; 1H NMR
127.6,127.6,126.6, 126.1,126.1,125.5, 66.3, 61.1, 59.5, 58.8, 48.5, 37.0,
32.7, 13.8 ppm; HRMS (ESI) m/z calcd for C21H24O4 (MþþNa)
363.1574, found 363.1572. The enantiomeric excess (90% ee) was
(500 MHz, CDCl3)
4.23 (s, 2H), 4.05e3.96 (m, 2H), 3.79 (s, 3H), 3.69 (d, J¼5.6 Hz, 2H),
d
¼7.05 (d, J¼8.7 Hz, 2H), 6.8 (d, J¼8.7 Hz, 2H),